semaglutide eligibility across all current indications for us adults What BMI Do You Need to Qualify GLP-1? Semaglutide for Weight Loss: What

Who should I ask about my specific case

However, its important to note that this study showed an association, not necessarily causation

FDA Telehealth Warning Letters In early March 2026, the FDA reportedly issued warning letters to multiple telehealth companies regarding compounded GLP-1 marketing practices, with concerns including misleading marketing claims, implications of equivalence with FDA-approved drugs, and obscuring product sourcing

A., Alavi-Rad, S., Boustaninejad, M., Afrisham, R., Abbasnezhad, A., & Alipour, M

The prescription medication is a GLP-1 receptor agonist that mimics a naturally occurring hormone in the body